BRIEF-Sandoz Receives 8th European Commission Approval For Biosimilar Ziextenzo
1 分钟阅读
Nov 27 (Reuters) - Novartis AG:
* SANDOZ RECEIVES EIGHTH EUROPEAN COMMISSION APPROVAL FOR A BIOSIMILAR WITH ZIEXTENZO® (PEGFILGRASTIM) Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)